{"transactions":[{"id":3901777,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-07T17:16:54.000Z","date":"2018-06-05","kind":"exercise","acquired":false,"shares":11155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested."}],"balance_after":0,"derivative":{"exercise_price":19.21,"expiration_date":"2018-11-11","underlying":"Common Stock","underlying_shares":11155},"source":{"system":"sec-edgar","filing":"0001681622-18-000020","document":"wf-form4_152840619676269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000168162218000020/wf-form4_152840619676269.xml","form_type":"4"}},{"id":3901776,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2018-06-07T17:16:54.000Z","date":"2018-06-05","kind":"sale","acquired":false,"shares":11155,"price":37.4182,"value":417400.021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2018. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.15 to $37.86."}],"balance_after":16816,"source":{"system":"sec-edgar","filing":"0001681622-18-000020","document":"wf-form4_152840619676269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000168162218000020/wf-form4_152840619676269.xml","form_type":"4"}},{"id":3901775,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2018-06-07T17:16:54.000Z","date":"2018-06-05","kind":"exercise","acquired":true,"shares":11155,"price":19.21,"value":214287.55,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned at end of reporting period reflect 236 shares purchased on April 27, 2018 under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan."}],"balance_after":27971,"source":{"system":"sec-edgar","filing":"0001681622-18-000020","document":"wf-form4_152840619676269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000168162218000020/wf-form4_152840619676269.xml","form_type":"4"}},{"id":4048013,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-02-20T20:50:15.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":15095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of options vests one year from grant date, and the remaining options vests monthly thereafter on a pro rata basis."}],"balance_after":15095,"derivative":{"exercise_price":37.1,"expiration_date":"2025-02-16","underlying":"Common Stock","underlying_shares":15095},"source":{"system":"sec-edgar","filing":"0001214659-18-001418","document":"marketforms-41072.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465918001418/marketforms-41072.xml","form_type":"4"}},{"id":4048012,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2018-02-20T20:50:15.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":4805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date."}],"balance_after":4805,"derivative":{"underlying":"Common Stock","underlying_shares":4805},"source":{"system":"sec-edgar","filing":"0001214659-18-001418","document":"marketforms-41072.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465918001418/marketforms-41072.xml","form_type":"4"}},{"id":4048011,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2018-02-20T20:50:15.000Z","date":"2018-02-15","kind":"exercise","acquired":false,"shares":1664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1664},"source":{"system":"sec-edgar","filing":"0001214659-18-001418","document":"marketforms-41072.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465918001418/marketforms-41072.xml","form_type":"4"}},{"id":4048010,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2018-02-20T20:50:15.000Z","date":"2018-02-15","kind":"exercise","acquired":false,"shares":1766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."}],"balance_after":1767,"derivative":{"underlying":"Common Stock","underlying_shares":1766},"source":{"system":"sec-edgar","filing":"0001214659-18-001418","document":"marketforms-41072.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465918001418/marketforms-41072.xml","form_type":"4"}},{"id":4048009,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2018-02-20T20:50:15.000Z","date":"2018-02-15","kind":"exercise","acquired":false,"shares":1592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date."}],"balance_after":4479,"derivative":{"underlying":"Common Stock","underlying_shares":1592},"source":{"system":"sec-edgar","filing":"0001214659-18-001418","document":"marketforms-41072.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465918001418/marketforms-41072.xml","form_type":"4"}},{"id":4048008,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2018-02-20T20:50:15.000Z","date":"2018-02-15","kind":"tax_withholding","acquired":false,"shares":1529,"price":37.1,"value":56725.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein."}],"balance_after":16580,"source":{"system":"sec-edgar","filing":"0001214659-18-001418","document":"marketforms-41072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465918001418/marketforms-41072.xml","form_type":"4"}},{"id":4048007,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2018-02-20T20:50:15.000Z","date":"2018-02-15","kind":"exercise","acquired":true,"shares":1664,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."}],"balance_after":18109,"source":{"system":"sec-edgar","filing":"0001214659-18-001418","document":"marketforms-41072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465918001418/marketforms-41072.xml","form_type":"4"}},{"id":4048006,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2018-02-20T20:50:15.000Z","date":"2018-02-15","kind":"exercise","acquired":true,"shares":1766,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."}],"balance_after":16445,"source":{"system":"sec-edgar","filing":"0001214659-18-001418","document":"marketforms-41072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465918001418/marketforms-41072.xml","form_type":"4"}},{"id":4048005,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2018-02-20T20:50:15.000Z","date":"2018-02-15","kind":"exercise","acquired":true,"shares":1592,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 229 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan"}],"balance_after":14679,"source":{"system":"sec-edgar","filing":"0001214659-18-001418","document":"marketforms-41072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465918001418/marketforms-41072.xml","form_type":"4"}},{"id":4162332,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-15T21:04:42.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":6328,"price":28.15,"value":178133.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares were acquired in connection with the company's separation from Varian Medical Systems, Inc. and were inadvertently omitted from column 5 in the Form 4 dated February 17, 2017."}],"balance_after":12858,"source":{"system":"sec-edgar","filing":"0001214659-17-006770","document":"marketforms-40122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917006770/marketforms-40122.xml","form_type":"5"}},{"id":4409922,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-02T15:55:04.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":18089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.53,"expiration_date":"2017-05-14","underlying":"Common Stock","underlying_shares":18089},"source":{"system":"sec-edgar","filing":"0001214659-17-001583","document":"marketforms-38130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001583/marketforms-38130.xml","form_type":"4"}},{"id":4409921,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-03-02T15:55:04.000Z","date":"2017-02-28","kind":"sale","acquired":false,"shares":18089,"price":34.9985,"value":633087.8665,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.29 to $34.26."}],"balance_after":6530,"source":{"system":"sec-edgar","filing":"0001214659-17-001583","document":"marketforms-38130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001583/marketforms-38130.xml","form_type":"4"}},{"id":4409920,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-03-02T15:55:04.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":18089,"price":17.53,"value":317100.17,"ownership":{"direct":true},"balance_after":24619,"source":{"system":"sec-edgar","filing":"0001214659-17-001583","document":"marketforms-38130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001583/marketforms-38130.xml","form_type":"4"}},{"id":4439646,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-02-17T20:30:56.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":67450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of shares vests one year from grant date, and the remaining 75% vests monthly thereafter."}],"balance_after":67450,"derivative":{"exercise_price":31.08,"expiration_date":"2024-02-16","underlying":"Common Stock","underlying_shares":67450},"source":{"system":"sec-edgar","filing":"0001214659-17-001255","document":"marketforms-37978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001255/marketforms-37978.xml","form_type":"4"}},{"id":4439645,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-02-17T20:30:56.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":6371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date."}],"balance_after":11568,"derivative":{"underlying":"Common Stock","underlying_shares":6370},"source":{"system":"sec-edgar","filing":"0001214659-17-001255","document":"marketforms-37978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001255/marketforms-37978.xml","form_type":"4"}},{"id":4439644,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-02-17T20:30:56.000Z","date":"2017-02-15","kind":"exercise","acquired":false,"shares":1767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These Restricted Stock Units vest in three equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These Restricted Stock Units vest in three equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."}],"balance_after":3533,"derivative":{"underlying":"Common Stock","underlying_shares":1767},"source":{"system":"sec-edgar","filing":"0001214659-17-001255","document":"marketforms-37978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001255/marketforms-37978.xml","form_type":"4"}},{"id":4439643,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-02-17T20:30:56.000Z","date":"2017-02-15","kind":"exercise","acquired":false,"shares":1664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These Restricted Stock Units vest in two equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These Restricted Stock Units vest in two equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."}],"balance_after":1664,"derivative":{"underlying":"Common Stock","underlying_shares":1664},"source":{"system":"sec-edgar","filing":"0001214659-17-001255","document":"marketforms-37978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001255/marketforms-37978.xml","form_type":"4"}},{"id":4439642,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-02-17T20:30:56.000Z","date":"2017-02-15","kind":"exercise","acquired":false,"shares":4323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4323},"source":{"system":"sec-edgar","filing":"0001214659-17-001255","document":"marketforms-37978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001255/marketforms-37978.xml","form_type":"4"}},{"id":4439641,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-02-17T20:30:56.000Z","date":"2017-02-15","kind":"exercise","acquired":false,"shares":2002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2002},"source":{"system":"sec-edgar","filing":"0001214659-17-001255","document":"marketforms-37978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001255/marketforms-37978.xml","form_type":"4"}},{"id":4439640,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-02-17T20:30:56.000Z","date":"2017-02-15","kind":"tax_withholding","acquired":false,"shares":3226,"price":29.93,"value":96554.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein."}],"balance_after":6530,"source":{"system":"sec-edgar","filing":"0001214659-17-001255","document":"marketforms-37978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001255/marketforms-37978.xml","form_type":"4"}},{"id":4439639,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-02-17T20:30:56.000Z","date":"2017-02-15","kind":"exercise","acquired":true,"shares":1767,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."}],"balance_after":9756,"source":{"system":"sec-edgar","filing":"0001214659-17-001255","document":"marketforms-37978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001255/marketforms-37978.xml","form_type":"4"}},{"id":4439638,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-02-17T20:30:56.000Z","date":"2017-02-15","kind":"exercise","acquired":true,"shares":1664,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."}],"balance_after":7989,"source":{"system":"sec-edgar","filing":"0001214659-17-001255","document":"marketforms-37978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001255/marketforms-37978.xml","form_type":"4"}},{"id":4439637,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-02-17T20:30:56.000Z","date":"2017-02-15","kind":"exercise","acquired":true,"shares":4323,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."}],"balance_after":6325,"source":{"system":"sec-edgar","filing":"0001214659-17-001255","document":"marketforms-37978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001255/marketforms-37978.xml","form_type":"4"}},{"id":4439636,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-02-17T20:30:56.000Z","date":"2017-02-15","kind":"exercise","acquired":true,"shares":2002,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit converts into common stock on a one-for-one basis."}],"balance_after":2002,"source":{"system":"sec-edgar","filing":"0001214659-17-001255","document":"marketforms-37978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917001255/marketforms-37978.xml","form_type":"4"}},{"id":4459615,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-02-09T21:02:32.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"shares","element":"transactionShares","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These RSUs vest in three equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."}],"balance_after":14953,"derivative":{"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001214659-17-000915","document":"marketforms-37780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000915/marketforms-37780.xml","form_type":"4/A","original_submission_date":"2017-01-31"}},{"id":4459614,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-02-09T21:02:32.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":3328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"shares","element":"transactionShares","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"These RSUs vest in two equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."}],"balance_after":14953,"derivative":{"expiration_date":"2019-02-15","underlying":"Common Stock","underlying_shares":3328},"source":{"system":"sec-edgar","filing":"0001214659-17-000915","document":"marketforms-37780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000915/marketforms-37780.xml","form_type":"4/A","original_submission_date":"2017-01-31"}},{"id":4459613,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-02-09T21:02:32.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":2002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"shares","element":"transactionShares","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"These RSUs vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."}],"balance_after":14953,"derivative":{"expiration_date":"2018-02-15","underlying":"Common Stock","underlying_shares":2002},"source":{"system":"sec-edgar","filing":"0001214659-17-000915","document":"marketforms-37780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000915/marketforms-37780.xml","form_type":"4/A","original_submission_date":"2017-01-31"}},{"id":4459612,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-02-09T21:02:32.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":4323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"shares","element":"transactionShares","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"These RSUs vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"In connection with the spin-off, each outstanding restricted stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award.  This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU.  Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."}],"balance_after":14953,"derivative":{"expiration_date":"2018-02-15","underlying":"Common Stock","underlying_shares":4323},"source":{"system":"sec-edgar","filing":"0001214659-17-000915","document":"marketforms-37780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000915/marketforms-37780.xml","form_type":"4/A","original_submission_date":"2017-01-31"}},{"id":4459611,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-02-09T21:02:32.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":14703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."}],"balance_after":14703,"derivative":{"exercise_price":25.17,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":14703},"source":{"system":"sec-edgar","filing":"0001214659-17-000915","document":"marketforms-37780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000915/marketforms-37780.xml","form_type":"4/A","original_submission_date":"2017-01-31"}},{"id":4459610,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-02-09T21:02:32.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":12472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."}],"balance_after":12472,"derivative":{"exercise_price":30.74,"expiration_date":"2022-02-13","underlying":"Common Stock","underlying_shares":12472},"source":{"system":"sec-edgar","filing":"0001214659-17-000915","document":"marketforms-37780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000915/marketforms-37780.xml","form_type":"4/A","original_submission_date":"2017-01-31"}},{"id":4459609,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-02-09T21:02:32.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":13790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 21, 2014 and the remaining vests monthly thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."}],"balance_after":13790,"derivative":{"exercise_price":27.77,"expiration_date":"2021-02-21","underlying":"Common Stock","underlying_shares":13790},"source":{"system":"sec-edgar","filing":"0001214659-17-000915","document":"marketforms-37780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000915/marketforms-37780.xml","form_type":"4/A","original_submission_date":"2017-01-31"}},{"id":4459608,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-02-09T21:02:32.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":13530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option fully vested three years from date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."}],"balance_after":13530,"derivative":{"exercise_price":22.84,"expiration_date":"2019-11-09","underlying":"Common Stock","underlying_shares":13530},"source":{"system":"sec-edgar","filing":"0001214659-17-000915","document":"marketforms-37780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000915/marketforms-37780.xml","form_type":"4/A","original_submission_date":"2017-01-31"}},{"id":4459607,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-02-09T21:02:32.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":11155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option fully vested three years from date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."}],"balance_after":11155,"derivative":{"exercise_price":19.21,"expiration_date":"2018-11-11","underlying":"Common Stock","underlying_shares":11155},"source":{"system":"sec-edgar","filing":"0001214659-17-000915","document":"marketforms-37780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000915/marketforms-37780.xml","form_type":"4/A","original_submission_date":"2017-01-31"}},{"id":4459606,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-02-09T21:02:32.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":18089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option fully vested three years from date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In connection with the spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award.  This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant."}],"balance_after":18089,"derivative":{"exercise_price":17.53,"expiration_date":"2017-05-14","underlying":"Common Stock","underlying_shares":18089},"source":{"system":"sec-edgar","filing":"0001214659-17-000915","document":"marketforms-37780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000915/marketforms-37780.xml","form_type":"4/A","original_submission_date":"2017-01-31"}},{"id":4475456,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-01-31T21:03:45.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"shares","element":"transactionShares","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These RSUs vest in three equal annual installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"These RSUs vest in three equal annual installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-17-000583","document":"marketforms-37693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000583/marketforms-37693.xml","form_type":"4"}},{"id":4475455,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-01-31T21:03:45.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"shares","element":"transactionShares","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"These RSUs vest in two equal annual installments beginning on February 13, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"These RSUs vest in two equal annual installments beginning on February 13, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-17-000583","document":"marketforms-37693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000583/marketforms-37693.xml","form_type":"4"}},{"id":4475454,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-01-31T21:03:45.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"shares","element":"transactionShares","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-17-000583","document":"marketforms-37693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000583/marketforms-37693.xml","form_type":"4"}},{"id":4475453,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-01-31T21:03:45.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"shares","element":"transactionShares","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"In connection with the Spin-off, each outstanding deferred stock unit (\"RSU\") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-17-000583","document":"marketforms-37693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000583/marketforms-37693.xml","form_type":"4"}},{"id":4475452,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-31T21:03:45.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."}],"balance_after":0,"derivative":{"expiration_date":"2023-02-12","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-17-000583","document":"marketforms-37693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000583/marketforms-37693.xml","form_type":"4"}},{"id":4475451,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-31T21:03:45.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."}],"balance_after":0,"derivative":{"expiration_date":"2022-02-13","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-17-000583","document":"marketforms-37693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000583/marketforms-37693.xml","form_type":"4"}},{"id":4475450,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-31T21:03:45.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 21, 2014 and the remaining vests monthly thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."}],"balance_after":0,"derivative":{"expiration_date":"2021-02-21","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-17-000583","document":"marketforms-37693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000583/marketforms-37693.xml","form_type":"4"}},{"id":4475449,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-31T21:03:45.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from November 9, 2012 and the remaining vests monthly thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."}],"balance_after":0,"derivative":{"expiration_date":"2019-11-09","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-17-000583","document":"marketforms-37693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000583/marketforms-37693.xml","form_type":"4"}},{"id":4475448,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-31T21:03:45.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from November 11, 2011 and the remaining vests monthly thereafter"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."}],"balance_after":0,"derivative":{"expiration_date":"2018-11-11","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-17-000583","document":"marketforms-37693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000583/marketforms-37693.xml","form_type":"4"}},{"id":4475447,"issuer":{"id":5135,"kind":"organization","name":"Varex Imaging Corp","symbol":"VREX"},"owners":[{"id":165928,"kind":"person","name":"LaCasce Carl E.","position":1,"cik":"0001695298","reported_name":"LaCasce Carl E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Sales & Marketing"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-31T21:03:45.000Z","date":"2017-01-28","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from May 14, 2010 and the remaining vests monthly thereafter"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. (\"Varian\") on January 28, 2017 (the \"Spin-off\"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock.  The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information."}],"balance_after":0,"derivative":{"expiration_date":"2017-05-14","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001214659-17-000583","document":"marketforms-37693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695298/000121465917000583/marketforms-37693.xml","form_type":"4"}}]}